The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effect of topotecan in advanced intraocular retinoblastoma with manageable toxicity.
I. A. Qaddoumi
No relevant relationships to disclose
C. Billups
No relevant relationships to disclose
C. F. Stewart
No relevant relationships to disclose
J. Wu
No relevant relationships to disclose
K. Helton
No relevant relationships to disclose
B. McCarville
No relevant relationships to disclose
T. E. Merchant
No relevant relationships to disclose
R. C. Brennan
No relevant relationships to disclose
B. Haik
No relevant relationships to disclose
C. Rodriguez-Galindo
No relevant relationships to disclose
M. W. Wilson
No relevant relationships to disclose